Establishment Labs Holdings, Inc. (NASDAQ:ESTA) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET
Company Participants
Juan Jose Chacon Quiros - Founder and CEO
Rajbir Denhoy - CFO
Conference Call Participants
Chris Cooley - Stephens
Zach Weiner - Jefferies
Josh Jennings - Cowen
Marie Thibault - BTIG
Philip Coover - Goldman Sachs
Anthony Petrone - Mizuho Group
Operator
Good afternoon. Welcome to Establishment Labs' Second Quarter 2022 Earnings Call. At this time, all participants will be in a listen-only mode. At the end of this call, we will open the line for a question-and-answer session and instructions will follow at that time. As a reminder, today's call is being recorded.
And I will now turn the call over to Raj Denhoy, Chief Financial Officer. Please go ahead.
Rajbir Denhoy
Thank you, operator and thank you, everyone, for joining us. With me today is Juan Jose Chacon Quiros, our Chief Executive Officer. Following our prepared remarks, we'll take your questions.
Before we begin, I would like to remind you that comments made by management during this call will include forward-looking statements within the meaning of federal securities laws. These include statements on Establishment Labs' financial outlook and the company's plans and timing for product development and sales.
These forward-looking statements are based on management's current expectations and involve risks and uncertainties. For a discussion of the principal risk factors and uncertainties that may affect our performance or cause actual results to differ materially from these statements, I encourage you to review our most recent annual and quarterly reports on Form 10-K and Form 10-Q as well as other SEC filings which are available on our website at establishmentlabs.com.
As a reminder, Establishment Labs received an investigational device exemption from the FDA for Motiva Implants and is undergoing a clinical trial to support regulatory approval in the United States. We continually seek to expand the geographies in which our products are regulatory approved. Please check to the local authorities for specific product availability.
The content of this conference call contains time-sensitive information accurate only as of the date of this live broadcast, August 8th, 2022. Except as required by law, Establishment Labs undertakes no obligation to revise or otherwise update any statements to reflect events or circumstances after the date of this call.
With that, it is my pleasure to turn the call over to our CEO, Juan Jose.
Juan Jose Chacon Quiros